Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Pharma and Consumer Health587M57.32%
Biologics438M42.77%
Inter-segment revenue elimination-1M-0.10%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States2.77B64.93%
Europe1.26B29.49%
Other355M8.33%
Elimination of revenue attributable to multiple locations-117M-2.74%
